Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunologic Memory | 7 | 2021 | 1377 | 0.850 |
Why?
|
Antigens, Neoplasm | 6 | 2023 | 1998 | 0.810 |
Why?
|
T-Lymphocytes | 10 | 2023 | 10263 | 0.650 |
Why?
|
Substrate Specificity | 1 | 2021 | 1750 | 0.560 |
Why?
|
Melanoma | 4 | 2022 | 5702 | 0.520 |
Why?
|
Hematopoietic Stem Cell Transplantation | 11 | 2024 | 5753 | 0.480 |
Why?
|
Cell Tracking | 1 | 2015 | 139 | 0.470 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2023 | 4652 | 0.430 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2022 | 4410 | 0.400 |
Why?
|
Genetic Engineering | 2 | 2015 | 936 | 0.360 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3942 | 0.340 |
Why?
|
Receptors, Antigen, T-Cell | 6 | 2024 | 2571 | 0.330 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2930 | 0.320 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2021 | 1362 | 0.250 |
Why?
|
Transplantation, Homologous | 7 | 2024 | 4860 | 0.250 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2024 | 3633 | 0.250 |
Why?
|
Epitopes | 2 | 2021 | 2526 | 0.220 |
Why?
|
Single-Cell Analysis | 4 | 2024 | 2535 | 0.210 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5860 | 0.200 |
Why?
|
Immunotherapy | 4 | 2023 | 4747 | 0.200 |
Why?
|
Cancer Vaccines | 2 | 2021 | 1042 | 0.200 |
Why?
|
Blood | 1 | 2024 | 598 | 0.200 |
Why?
|
Antineoplastic Agents | 2 | 2023 | 13644 | 0.180 |
Why?
|
Peptides | 3 | 2021 | 4347 | 0.170 |
Why?
|
Neoplasms | 5 | 2024 | 22350 | 0.170 |
Why?
|
HLA Antigens | 2 | 2023 | 1339 | 0.170 |
Why?
|
Phenotype | 4 | 2024 | 16722 | 0.160 |
Why?
|
DNA, Mitochondrial | 1 | 2024 | 872 | 0.160 |
Why?
|
Lymphocyte Count | 3 | 2017 | 794 | 0.160 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1503 | 0.160 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2019 | 657 | 0.150 |
Why?
|
Antigen-Presenting Cells | 1 | 2022 | 960 | 0.150 |
Why?
|
Clonal Anergy | 1 | 2019 | 169 | 0.150 |
Why?
|
Genes, Transgenic, Suicide | 2 | 2015 | 34 | 0.150 |
Why?
|
Monitoring, Immunologic | 1 | 2018 | 99 | 0.150 |
Why?
|
Thymidine Kinase | 2 | 2015 | 286 | 0.150 |
Why?
|
Databases, Protein | 1 | 2019 | 390 | 0.140 |
Why?
|
Immunity | 1 | 2023 | 1002 | 0.140 |
Why?
|
Myocarditis | 1 | 2024 | 802 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 838 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2020 | 827 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 371 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.120 |
Why?
|
Interleukin-7 | 2 | 2012 | 146 | 0.120 |
Why?
|
NF-kappa B | 1 | 2023 | 2493 | 0.120 |
Why?
|
Adoptive Transfer | 1 | 2017 | 828 | 0.120 |
Why?
|
Tumor Cells, Cultured | 1 | 2022 | 6105 | 0.120 |
Why?
|
Lymphopoiesis | 1 | 2015 | 133 | 0.110 |
Why?
|
Lymphocyte Depletion | 1 | 2015 | 606 | 0.110 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2023 | 1433 | 0.110 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2012 | 19 | 0.100 |
Why?
|
Myelodysplastic Syndromes | 1 | 2023 | 1403 | 0.100 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2023 | 1642 | 0.100 |
Why?
|
Clone Cells | 1 | 2015 | 1670 | 0.100 |
Why?
|
Interleukin-15 | 1 | 2012 | 186 | 0.100 |
Why?
|
Neoadjuvant Therapy | 1 | 2023 | 2902 | 0.100 |
Why?
|
Cyclophosphamide | 1 | 2017 | 2234 | 0.100 |
Why?
|
Myocardium | 1 | 2024 | 4765 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2039 | 0.090 |
Why?
|
Tissue Donors | 2 | 2024 | 2392 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3667 | 0.090 |
Why?
|
Humans | 29 | 2024 | 766812 | 0.090 |
Why?
|
Cell Line, Tumor | 3 | 2023 | 17089 | 0.090 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1383 | 0.090 |
Why?
|
Antigens | 1 | 2015 | 1442 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6066 | 0.080 |
Why?
|
Proteome | 1 | 2019 | 1894 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9528 | 0.080 |
Why?
|
Killer Cells, Natural | 1 | 2017 | 2209 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2017 | 10451 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2019 | 12795 | 0.070 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 11924 | 0.070 |
Why?
|
Antigen Presentation | 2 | 2023 | 1250 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3600 | 0.060 |
Why?
|
Ventricular Myosins | 1 | 2024 | 65 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2017 | 5143 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4215 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2012 | 1814 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2020 | 3788 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5389 | 0.060 |
Why?
|
Recurrence | 3 | 2023 | 8507 | 0.060 |
Why?
|
Glioblastoma | 1 | 2018 | 3458 | 0.050 |
Why?
|
Chemical Fractionation | 1 | 2021 | 60 | 0.050 |
Why?
|
Gene Transfer Techniques | 2 | 2017 | 1206 | 0.040 |
Why?
|
Autoantigens | 1 | 2024 | 890 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1925 | 0.040 |
Why?
|
Troponin I | 1 | 2024 | 659 | 0.040 |
Why?
|
Mutation | 1 | 2024 | 30214 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 786 | 0.040 |
Why?
|
Ribonuclease H | 1 | 2019 | 52 | 0.040 |
Why?
|
Microscopy | 1 | 2024 | 902 | 0.040 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2019 | 40 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2017 | 5193 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2023 | 764 | 0.040 |
Why?
|
Receptors, KIR | 1 | 2019 | 114 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2023 | 754 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 59939 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13489 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1150 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 207 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2023 | 65286 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 980 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 996 | 0.040 |
Why?
|
Adult | 8 | 2024 | 223305 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1802 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 928 | 0.040 |
Why?
|
Exons | 1 | 2023 | 2392 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 342 | 0.030 |
Why?
|
Peptide Hydrolases | 1 | 2019 | 610 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15564 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1521 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21162 | 0.030 |
Why?
|
Female | 9 | 2024 | 396532 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 223267 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2573 | 0.030 |
Why?
|
Aged | 5 | 2024 | 171344 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1198 | 0.030 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2015 | 89 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2019 | 1442 | 0.030 |
Why?
|
Male | 7 | 2024 | 364154 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2021 | 2198 | 0.030 |
Why?
|
Fibroblasts | 1 | 2024 | 4166 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 40149 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2019 | 4168 | 0.030 |
Why?
|
Dendritic Cells | 1 | 2024 | 2747 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2887 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1319 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2413 | 0.030 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 3079 | 0.030 |
Why?
|
Blood Donors | 1 | 2015 | 344 | 0.030 |
Why?
|
Ligands | 1 | 2019 | 3274 | 0.030 |
Why?
|
L-Selectin | 1 | 2012 | 212 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4425 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2019 | 2413 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4787 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1962 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2014 | 899 | 0.020 |
Why?
|
Proteomics | 1 | 2024 | 3915 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2631 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 13036 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2017 | 3605 | 0.020 |
Why?
|
Haplotypes | 1 | 2015 | 2726 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2801 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6896 | 0.020 |
Why?
|
Antigens, CD | 1 | 2019 | 4033 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2012 | 1836 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5502 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2012 | 1867 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9514 | 0.020 |
Why?
|
Mice, SCID | 1 | 2012 | 2626 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5795 | 0.020 |
Why?
|
Thymus Gland | 1 | 2012 | 1266 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22248 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2015 | 11657 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2721 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2012 | 1320 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 4570 | 0.020 |
Why?
|
DNA Methylation | 1 | 2018 | 4427 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9407 | 0.010 |
Why?
|
Prospective Studies | 2 | 2023 | 54872 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18986 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1520 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5749 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20146 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8540 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7585 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14073 | 0.010 |
Why?
|
Animals | 3 | 2017 | 168939 | 0.010 |
Why?
|
Mice | 2 | 2017 | 81898 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23618 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 81657 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20710 | 0.000 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_